Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
IASLC Academy
IASLC Academy
Amazing Case Race 2024
Publications, Resources & Guidelines
News
News
ILCN
WCLC 2024 News
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 157 - 168 items out of 1271 results
ILCN article
Real-World Data Shows Less Benefit for Mesothelioma from Checkpoint Inhibitors Vs. Clinical Trials
ILCN article
Real-World Data Show That Survival Just as Good With Carboplatin Therapy as With Cisplatin Therapy in Malignant Pleural Mesothelioma
ILCN article
A Holistic Approach to Patient Care
ILCN article
TKI Plus Checkpoint Inhibitor Without Chemotherapy Shows Promise as Initial Option in Advanced NSCLC
ILCN article
Co-mutations in DNA Damage-Response Pathways May Predict Effectiveness of Checkpoint Inhibitors in NSCLC
ILCN article
Lung Cancer Biomarker Testing Patterns Varied Widely in Japan
ILCN article
Management of Long-Term Immune-Related Toxicities Needed in NSCLC
ILCN article
Raising Awareness about Lung Cancer Screening among Minorities, People Who Smoke
ILCN article
Additional ADAURA Analyses Help Support the Benefit of Adjuvant Osimertinib in Patients With Resected EGFR-Mutated NSCLC
ILCN article
Lung Cancer Screening for Women: Understanding the Risks and the Benefits
ILCN article
Becoming a Critical Actor—Learning about Improving Equity and Inclusion in the Workplace
ILCN article
LGBT Cancer Survivors and Disparities-Related Barriers That May Affect Survival
Pagination
First
First page
‹
Previous page
…
10
11
12
13
14
15
16
17
18
…
›
Next page
Last
Last page